Israeli-based MediWound Ltd (NASDAQ:MDWD) has developed a treatment to remove dead skin from burn wounds, and it has been approved by the European Medicines Agency. Mediwound Ltd (NASDAQ:MDWD) stock performance was -6.88% in last session and finished the day at $14.48. Traded volume was 485.2K shares in the last session and the average volume of the stock remained 1.40million shares.
Five Star Quality Care, Inc. (NYSE:FVE) was downgraded by investment analysts at JMP Securities from an “outperform” rating to a “market perform” rating in a note issued to investors on Thursday, American Banking & Market News reports. Five Star Quality Care, Inc. (NYSE:FVE) dropped -9.49 percent to $4.96 Thursday on volume of 603.00K shares. The intra-day range of the stock was $4.95 to $5.35. Five Star Quality Care, Inc. (NYSE:FVE) has a market capitalization of $241.15million.
Ventrus Biosciences Inc (NASDAQ:VTUS)’s shares jumped 2.94% to $1.40. The company on Feb. 12 announced top line efficacy and safety results from the second Phase 3 clinical trial of Diltiazem Hydrochloride 2% Cream (VEN 307) in patients with pain related to anal fissure (AF). Ventrus Biosciences Inc (NASDAQ:VTUS)’s stock on Mar 27, 2014 reported a decrease of -5.26% to the closing price of $1.26. Its fifty two weeks range is $1.22 -$4.69. The total market capitalization recorded $26.28million. The overall volume in the last trading session was 764.00K shares. In its share capital, VTUS has 19.90million outstanding shares.
On March 3, 2014 Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) announced that they had recently held a pre-Investigational New Drug (pre-IND) meeting with the US. Food and Drug Administration (FDA) to discuss the development of TNX-201, a single isomer isometheptene (IMH) for the relief of episodic tension-type headache (ETTH). On Thursday, shares of Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) dropped -5.64% to close the day at $10.04. Company monthly performance is recorded as -29.49%. Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) quarterly revenue growth is 0.40%.